LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | SB590885 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4368 | 4156 | 1.0510 | 1.0726 |
MCF7 | PIK-93 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4937 | 4156 | 1.1880 | 1.2676 |
MCF7 | KIN001-043 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3752 | 4156 | 0.9028 | 0.8617 |
MCF7 | Alpelisib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3450 | 4156 | 0.8303 | 0.7585 |
MCF7 | Luminespib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 1413 | 4156 | 0.3401 | 0.0610 |
MCF7 | A443654 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 982 | 4156 | 0.2364 | -0.0865 |
MCF7 | OSI-027 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3019 | 4156 | 0.7265 | 0.6108 |
MCF7 | XMD11-85h | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3496 | 4156 | 0.8412 | 0.7741 |
MCF7 | HG-6-64-01 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4613 | 4156 | 1.1101 | 1.1566 |
MCF7 | WH-4-025 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 2787 | 4156 | 0.6707 | 0.5315 |
MCF7 | WZ-4-145 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2859 | 4156 | 0.6881 | 0.5561 |
MCF7 | XMD16-144 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 1640 | 4156 | 0.3946 | 0.1385 |
MCF7 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3502 | 4156 | 0.8428 | 0.7763 |
MCF7 | Buparlisib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 2627 | 4156 | 0.6322 | 0.4767 |
MCF7 | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3692 | 4156 | 0.8883 | 0.8411 |
MCF7 | Canertinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3572 | 4156 | 0.8595 | 0.8001 |
MCF7 | Celastrol | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3998 | 4156 | 0.9620 | 0.9460 |
MCF7 | CGP60474 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 774 | 4156 | 0.1862 | -0.1580 |
MCF7 | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 587 | 4156 | 0.1413 | -0.2219 |
MCF7 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3240 | 4156 | 0.7796 | 0.6864 |
MCF7 | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3363 | 4156 | 0.8092 | 0.7284 |
MCF7 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4537 | 4156 | 1.0918 | 1.1306 |
MCF7 | Crizotinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3061 | 4156 | 0.7367 | 0.6253 |
MCF7 | Momelotinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3478 | 4156 | 0.8368 | 0.7678 |
MCF7 | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 1273 | 4156 | 0.3065 | 0.0131 |